SPONSOR
Suzhou Genhouse Bio Co., Ltd.
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Advanced Solid Tumors With MAPK Signal Pathway Mutations
Clinical Trials by Suzhou Genhouse Bio Co., Ltd.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology